Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.72678 | 31 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.74103 | 33 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.71975 | 32 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.62257 | 72 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.72265 | 34 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.73016 | 29 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.73829 | 30 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.98839 | 43 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.72275 | 33 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.72998 | 33 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.72379 | 32 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.73027 | 34 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.7249 | 32 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.73417 | 33 |